• Financial Services

    OBG’s banking, insurance and investment coverage looks at revenue and profit trends, market share changes, foreign entry and regulatory developments while our capital markets sector analyses provide information on the stock and bond markets, IPO activity and regulatory changes.
Displaying 4243 - 4248 of 4356

Since the global financial crisis hit in late 2007, portfolio investors worldwide have cast a wider net, looking for capital gains in a world where economic growth is far from certain. In their search for markets that have shown resilience, many have turned to the countries of South-east Asia.

What priorities are outlined in the 2010-14 master plan to help Indonesia sustain development?

Articles & Analysis | Kalbe Farma: Pharmaceuticals from The Report: Indonesia 2012

THE COMPANY: In line with expectations, Kalbe Farma (KLBF) reported increased earnings in the first half of 2011. Sales grew approximately 5.14% year-on-year (y-o-y) to Rp4.94trn ($592.8m). This figure is equal to around 44.07% of the full-year projection of Rp11.22trn ($2.38bn). Pharmaceutical packaging...

To what extent will the industry be able to maintain current increases in loan-to-deposit (LDR) ratios while ensuring adequate risk management?

With GDP growth at 6.1% in 2010 and forecast to reach 6.6% in 2011, on the back of buoyant consumption, expectations are high for insurance in Indonesia.

Articles & Analysis | Jasa Marga: Toll roads from The Report: Indonesia 2012

THE COMPANY: Jasa Marga, established in 1978, was the first toll-road operator in Indonesia. The company is the market leader of toll road operators, managing approximately 532 km, or 72%, of toll roads in the country. Jasa Marga is currently in the process of developing another 200 km of toll roads....

Covid-19 Economic Impact Assessments

Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.

Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.

Register Here×

Product successfully added to shopping cart